Because little is known about the etiology of non-Hodgkin lymphoma (NHL), a heterogeneous disease, and because dietary factors are modifiable, the authors examined the associations between nutrients related to one-carbon metabolism and risk of NHL in a population-based case-control study of Connecticut women diagnosed between 1996 and 2000. A total of 594 cases and 710 controls completed a food...

Aim: To report the clinical courses of two patients, one with Hodgkin’s lymphoma (HL) and Non-Hodgkin’s (NHL), who developed severe refractory acute respiratory distress syndrome (ARDS) were treated veno-venous extracorporeal membrane oxygenation (VV ECMO). Case report: Both patients chemotherapy-associated febrile neutropenia followed by pneumonia ARDS, after which they transferred to intensiv...

Background: despite the development of new highly effective treatments in field Non-Hodgkin's lymphoma (NHL), allogeneic hematopoietic stem cell transplantation (alloHSCT) still remains a potentially curative option for virtually all type NHL. Due to concerns about its high toxicity, alloHSCT NHL is reserved as ultimate line treatment. Introduction reduced intensity conditioning regimens, usage...

We report a case of severe and fatal aplastic anemia during an episode of infectious mononucleosis caused by Epstein-Barr (EB) virus infection. The 13-year-old female patient had shown normal hematological findings and had previously undergone repeated chemotherapy and autologous bone marrow transplantation for refractory non-Hodgkin malignant lymphoma (NHL). She was probably in an immuno-suppr...

BACKGROUND Anaemia is a common feature of lympho-proliferative disorders and is an important cause of poor quality of life in these patients. When indicated, packed red blood cells (PRBC) units are transfused to treat anaemia. Objective of this study was to identify risk factors associated with PRBC transfusions in lymphoma patients. METHODS This was a retrospective study done on Hodgkin lymp...

for approximately 3% of primary malignant bone tumors and for 5% of extranodal lymphoma (1). In the majority of cases, the tumor involves the extremities and less frequently the axial skeleton. Disseminated malignant lymphoma is extremely rare, representing 0.8% of malignant non-Hodgkin’s lymphoma(NHL) (2). Here, we encountered primary NHL of bone involving the skull, spine, both upper and lowe...

Lymphoma rarely occurs during pregnancy, making this condition difficult to define. Lymphomas that occur in reproductive organs during pregnancy exhibit unique clinical characteristics. Among the limited cases, non-Hodgkin's lymphoma (NHL) shows a considerably higher incidence rate than Hodgkin's lymphoma (HL); NHL also displays clinical characteristics, such as high aggressiveness, advanced st...

OBJECTIVES To determine the prevalence of hepatitis C virus (HCV) infection in patients with B-cell non-Hodgkin's lymphoma (NHL) in British Columbia. DESIGN A cross-sectional analysis. SETTING The British Columbia Cancer Agency (BCCA), a Canadian provincial tertiary oncology referral center. SUBJECTS Consecutive patients with B-cell NHL registered onto the BCCA lymphoma database in 1996 a...

BACKGROUND AND OBJECTIVE The anthracycline analogue idarubicin, either alone or in combination with other antineoplastic drugs, has shown antileukemic activity in relapsed and refractory acute lymphoblastic leukemia (ALL). In an attempt to minimize the non-hematologic toxicity and obtain a potent antileukemic effect, MSKCC activated a pilot study in previously treated adult ALL, using HD-ARA-C ...

BACKGROUND AND OBJECTIVES Therapy for relapsed/refractory lymphomas should be based only on drugs not included in the front-line chemotherapy regimens. We adopted the strategy of using salvage chemotherapy to debulk disease and simultaneously mobilize stem cells, using a regimen based on ifosfamide and etoposide, (drugs not usually used for front-line treatment). DESIGN AND METHODS A three-dr...